Vrdoljak, E., Sekerija, M., Pleština, S., Belac Lovasić, I., Katalinić Janković, V., Garattini, L. ... Vončina, L. (2021). Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.. The European journal of health economics, 22. (1), 1. doi: 10.1007/s10198-020-01262-0
Vrdoljak, Eduard, et al. "Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.." The European journal of health economics, vol. 22, br. 1, 2021, str. 1. https://doi.org/10.1007/s10198-020-01262-0
Vrdoljak, Eduard, Mario Sekerija, Stjepko Pleština, Ingrid Belac Lovasić, Vera Katalinić Janković, Livio Garattini, Ana Bobinac i Luka Vončina. "Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.." The European journal of health economics 22, br. 1 (2021): 1. https://doi.org/10.1007/s10198-020-01262-0
Vrdoljak, E., et al. (2021) 'Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.', The European journal of health economics, 22(1), str. 1. doi: 10.1007/s10198-020-01262-0
Vrdoljak E, Sekerija M, Pleština S, Belac Lovasić I, Katalinić Janković V, Garattini L, i sur.. Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.. The European journal of health economics [Internet]. 2021. [pristupljeno 22.10.2024.];22(1):1. doi: 10.1007/s10198-020-01262-0
E. Vrdoljak, et al., "Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.", The European journal of health economics, vol. 22, br. 1, str. 1, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:652428. [Citirano: 22.10.2024.]